This is probably because breast cancer with HER-2 overexpression has higher pathological grading, higher pathological staging, and stronger infiltration, which induced the increase in tumor angiogenesis and immature blood vessels, ultimately leading to an increase in the Ktrans value. The gene discussed is ERBB2; the disease is neoplasm.